No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, and brake fluids; bio-polymers comprising guar and natural gums; biofuels; specialty chemicals, such as plasticisers, oil fields chemicals, bio-amines, methyl soyate, MDEA and MDEA derivatives, bio-potash granules, and C-Smart specialty products; molasses and grain based extra neutral alcohol; and specialty gases, including industrial and medical oxygen, food grade and industrial carbon dioxide, liquid argon and nitrogen, ethylene oxide, and bio ethylene oxide. It also provides Indian made foreign liquor, such as whiskey under Soulmate Blu and Single Reserve brands; vodka under Amazing brand; and rum under Zumba and Beach House XXX brands, as well as economy spirits under Bunty brand, and branded country liquor. In addition, the company offers natural active pharmaceutical ingredients, nutraceuticals, standardized botanical extracts, and nicotine derivatives. Further, its products find applications in pharma and healthcare; textiles; automotive; personal care; industrial and manufacturing; paints and coatings; oil and gas; food ingredients; packaging; potable spirits; and other various industries. The company also exports its products. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.
www.indiaglycols.comNo one on the platform currently holds INDIAGLYCO.NS.
No tracked institution reports a position in INDIAGLYCO.NS as of their last filing.
No one on the platform has traded INDIAGLYCO.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.3% | 10.5% | 9.2% | — | — | — |
| Rev. Growth % | 11.8% | 12.9% | ||||
| Profit Margin % | 7.0% | 7.0% | 5.3% | |||
| Free Cash Flow Margin % | -4.1% | -6.3% | -0.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $47.4B | +10.5% | $12.68 | $12.68–$12.68 | — | 1 |
| 2028 | $52.8B | +11.4% | $15.86 | $15.86–$15.86 | — | 1 |
| 2029 | $59.2B | +12.0% | $19.35 | $19.35–$19.35 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| INDIAGLYCO.NSIndia Glycols Limited | $266.20 | -5.00% | $17.8B | — |
| CHEMPLASTS.BOChemplast Sanmar Limited | $162.25 | -1.79% | $25.6B | — |
| CHEMPLASTS.NSChemplast Sanmar Limited | $162.40 | -1.65% | $25.7B | — |
| EPIGRAL.BOEpigral Limited | $1064.15 | -2.42% | $46.0B | — |
| EPIGRAL.NSEpigral Limited | $1070.60 | -1.98% | $46.2B | — |
| GHCL.BOGHCL Limited | $417.00 | -1.49% | $38.5B | — |
| GHCL.NSGHCL Limited | $416.50 | -1.57% | $38.4B | — |
Source: Financial Modeling Prep · peers by sector/industry